The company said it recorded goodwill and other asset impairment charges of $62 million related to its China business in Q3 2026. It said the decline in estimated fair value was driven by unfavorable changes in reimbursement rates and operating conditions across its non-dialysis hospital services.

1. 01

   The company said it recorded goodwill and other asset impairment charges of $62 million related to its China business in Q3 2026. It said the decline in estimated fair value was driven by unfavorable changes in reimbursement rates and operating conditions across its non-dialysis hospital services.

2. 02

   The company said operating cash flow decreased year over year for the 9 months ended September 30, 2026, mainly due to changes in working capital items, partially offset by higher operating results. Free cash flow also decreased over the same period.

3. 03

   The company said it raised $500 million of principal under an incremental Term Loan B-2 tranche during 2026 and had net borrowings of $80 million under its revolving credit facility over the 9 months. It also said it repurchased 5.8 million shares of common stock during the same period.

4. 04

   The company said that as of September 30, 2026, $1.42 billion of its $1.5 billion revolving credit facility was available and $80 million was drawn. There were no letters of credit under the revolving credit facility, and about $185 million of letters of credit were issued under a separate bilateral secured letter of credit facility.

Analysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Structured SEC financial data for this filing is not available yet. Please check the figures in the SEC filing.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.